Long acting betaxolol ocular inserts based on polymer composite

Current Drug Delivery

Volumn 10, Issue 4, 2013, Pages 384-393

  Gevariya, Hitesh B ^a   Patel, Jayvadan K ^b  

^a DHARMSINH DESAI UNIVERSITY   (India)

^b NOOTAN PHARMACY COLLEGE   (India)

Author keywords

Betaxolol hydrochloride; Ocular delivery; Once a day ocuserts; Polymer composite; Release kinetics; Sustained release

Indexed keywords

BETAXOLOL; MACROGOL; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG BIOAVAILABILITY; DRUG RELEASE; GLAUCOMA; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; KINETICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUSTAINED RELEASE FORMULATION; TENSILE STRENGTH;

EID: 84882787608     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811310040003     Document Type: Article

References (41)

1. Schoenwald, R.D. Ocular drug delivery: pharmacokinetic considerations. Clin. Pharmacokinet., 1990, 18 (4), 255-269.
2. VHL, L. Pre-corneal, corneal and post corneal factors. In: Drugs and pharmaceutical sciences, Swarbrick, J., Ed.; Marcel Dekker Inc: New York, 1993, pp 59-81.
3. Lee, V.H.L.; Robinson, J. R. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J. Pharm. Sci., 1979, 68 (6), 673-684.
4. Abdelkader, H.; Alany, R.G. Controlled and continuous release ocular drug delivery systems: pros and cons. Curr. Drug Del., 2012, 9 (4), 421-430.
5. Maurice, D. M.; Mishima, S. Ocular pharmacokinetics. In: Hand-book of Experimental Pharmacology, Sears, M. C., Ed.; Springer-Verlag: Berlin-Heidelberg, 1984, Vol. 69, pp 19-116.
6. Jtirvinen, K.; Jtirvinen, T.; Urtti, A. Ocular absorption following topical delivery. Adv. Drug Deliv. Rev., 1995, 16 (1), 3-19.
7. Kesavan, K.; Balasubramaniam, J.; Kant, S.; Singh, P.N.; Pandit, J.K. Newer approaches for optimal bioavailability of ocularly delivered drugs: review. Curr. Drug Del., 2011, 8 (2), 172-193.
8. Sohail, A.; Sushama, T.; Zeenat, I.K.; Gaurav, K.J.; Roop, K.K.; and Farhan, J.A. Assessment of Ocular Pharmacokinetics and Safety of Ganciclovir Loaded Nanoformulations. J. Biomed. Nanotechnol. 2011, 7, 144-145.
9. Abdus, S.; Sultana, Y.; Aqil, M. Liposomal drug delivery systems: An update review. Curr. Drug Del., 2007, 4 (4), 297-305.
10. Aggarwal, D.; Kaur, I.P. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int. J. Pharm., 2005, 290 (1), 155-159.
11. Attia, M. A.; Kassem, M. A.; Safwat, S. M. In vivo performance of [3H] dexamethasone ophthalmic film delivery systems in the rabbit eye. Int. J. Pharm., 1988, 47 (1), 21-30.
12. Bharath, S.; Hiremath, S.R. Ocular delivery systems of pefloxacin mesylate. Pharmazie, 1999, 54 (1), 55.
13. Li, H.Y.; Li, F.W.; Ping, Q.N. Determination of release rate, miotic activity and irritation of controlled release pilocarpine ophthalmic film. Nan Yao Xue, 1985, 16, 21-27.
14. Kenawy, E.R.; Bowlin, G.L.; Mansfield, K.; Layman, J.; Simpson, D.G.; Sanders, E.H.; Wnek, G.E. Release of tetracycline hydro-chloride from electrospun poly (ethylene-co-vinylacetate), poly (lactic acid), and a blend. J. Control. Release, 2002, 81 (1), 57-64.
15. Bhat, D.K.; Kumar, M.S. Biodegradability of PMMA blends with some cellulose derivatives. J. Polym. Environ., 2006, 14 (4), 385-392.
16. Hyppola, R.; Husson, I.; Sundholm, F. Evaluation of physical properties of plasticized ethyl cellulose films cast from ethanol solution Part I. Int. J. Pharm., 1996, 133 (1), 161-170.
17. Yamane, S.; Takayama, K.; Nagai, T. Effect of fractal dimension on drug permeation through porous ethylcellulose films. J. Control. Release, 1998, 50 (1), 103-109.
18. Abhilash, A.S.; Jayaprakash, S.; Nagarajan, M.; Dhachinamoorthi, D. Design and evaluation of timolo maleate ocuserts. Indian J. Pharm. Sci., 2005, 67 (3), 311-314.
19. Tanwar, Y.S.; Patel, D.; Sisodia, S.S. In vitro and in vivo evaluation of ocular inserts of ofloxacin. Daru, 2007, 15 (3), 139-145.
20. Pandit, J.K. In vitro characterization of physically reinforced ocular inserts of Indomethacin. Acta Pharm. Turc., 2004, 46, 17-24.
21. Murthy, S.N. Biodegradable polymers matrix based ocuserts of diclofenac sodium. Indian Drugs, 1997, 34, 336-338.
22. Gupta, A.; Sharma, S.K.; Ahuja, M. In vitro and in vivo evaluation of gellan based ocular inserts of phenylephrine. Acta Pharm. Sci., 2007, 49, 55-63.
23. Balasubramaniam, J.; Srinatha, A.; Pandit, J.K.; Nath, G. In vitro microbiological evaluation of polyvinyl alcohol-based ocular inserts of ciprofloxacin hydrochloride. Indian J. Pharm. Sci., 2006, 68 (5), 626-630.
24. Dandagi, P.M.; Manvi, F.V.; Patil, M.B.; Mastiholimath, V.S.; Rathod, R. Development and evaluation of ocular films of cromo-lyn sodium. Indian J. Pharm. Sci., 2004, 66 (3), 309-312.
25. Gupta, R.; Mukherjee, B. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethylcellulose matrices. Drug Dev. Ind. Pharm., 2003, 29 (1), 1-7.
26. Mundada, A.S.; Shrikhande, B.K. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochlo-ride. Drug Dev. Ind. Pharm., 2006, 32 (4), 443-448.
27. Sankar, V.; Chandrasekaran, A.K.; Durga, S.; Geetha, G.; Ravi-Chandran, V.A.; Vijayakumar, A. Design and evaluation of di-clofenac sodium ophthalmic inserts. The Indian Pharmacist, 2006, 98-100.
28. Ceschel, G.C.; Maffei, P.; Gentile, M. Design and evaluation of a new transdermal formulation containing chlorpheniramine maleate. Drug Dev. Ind. Pharm., 1999, 25 (9), 1035-1039.
29. Costa, P.; Sousa, L.J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 2001, 13 (2), 123-133.
30. Wilhelmus, K.R. The Draize eye test. Surv. Ophthalmol., 2001, 45 (6), 493-515.
31. Gupta, S.K.; Saxena, R.; Agarwal, R.; Galpalli, N.D.; Srivastava, S.; Agrawal, S.S. Estimation of intraocular pressure in rabbits using noncontact tonometer: A comparative evaluation with schiotz tonometer. Methods Find. Exp. Clin. Pharmacol., 2007, 29 (6), 405-410.
32. Kaur, I.P.; Singh, M.; Kanwar, M. Formulation and evaluation of ophthalmic preparations of acetazolamide. Int. J. Pharm., 2000, 199 (2), 119-127.
33. Matthews, B.R.; Wall, G.M. Stability storage and testing of ophthalmic products for global registration. Drug Dev. Ind. Pharm., 2000, 26 (12), 1227-1237.
34. Gonnering, R.; Edelhauser, H.F.; Van Horn, D.L.; Durant, W. The pH tolerance of rabbit and human corneal endothelium. Invest. Ophthalmol. Vis. Sci., 1979, 18 (4), 373-390.
35. Baldrian, J.; Sikora, A.; Steinharta, M.; Vicetek, P.; Amenitsch, H.; Bemstorff, S. Time-resolved SAXS study of crystallization of poly (ethylene oxide)/poly (methyl methacrylate) blends. Polymer, 1999, 40 (2), 439-445.
36. Guo, S.; Shen, L.; Feng, L. Surface characterization of blood compatible amphiphilic graft copolymers having uniform poly (ethyl-ene oxide) side chains. Polymer, 2001, 42 (3), 1017-1022.
37. Clothup, N.B.; Daly, L.H.; Wiberley, S.E. Introduction to infrared and Raman spectroscopy, Academic: San Diego, 1990.
38. Szymanski, H.A.; Erickson, R.E. Infrared band handbook, IFI/Plenum: New York, 1970.
39. Fan, L.; Singh, S.K. Controlled release: A quantitative treatment, Springer-Verlag: Berlin, 1989.
40. Yamsani, V.V.; Gannu, R.; Kolli, C.; Rao, M.E.B.; Yamsani, M.R. Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharm., 2007, 57 (2), 185-197.
41. Di Colo, G.; Burgalassi, S.; Chetoni, P.; Fiaschi, M.P.; Zambito, Y.; Saettone, M.F. Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly (ethyl-ene oxide). Int. J. Pharm., 2001, 220 (1), 169-177.